Sensus Healthcare (SRTS) Income from Continuing Operations (2016 - 2025)
Sensus Healthcare's (SRTS) quarterly Income from Continuing Operations came in at 3167000.0 in Q4 2025, down 304.85% year-on-year from 1546000.0 in Q4 2024, and down 235.84% quarter-over-quarter from 943000.0 in Q3 2025.
Sensus Healthcare (SRTS) Income from Continuing Operations (2016 - 2025) Analysis & Trends
Sensus Healthcare's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 3167000.0 for Q4 2025.
- On a quarterly basis, Income from Continuing Operations fell 304.85% year-over-year to 3167000.0 in Q4 2025; TTM through Dec 2025 was 7719000.0, a 216.13% decrease from a year earlier, with the FY2025 full-year figure at 7719000.0, down 216.13% from the prior year.
- Income from Continuing Operations slipped to 3167000.0 in Q4 2025 per SRTS's latest filing, from 943000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 5318000.0 in Q4 2021 and bottomed at 631290000.0 in Q1 2022.
- The 5-year median for Income from Continuing Operations is 42000.0 (2021), against an average of 30978800.0.
- Across the five-year window, Income from Continuing Operations surged 1985.49% in 2021 and slumped 56517.94% in 2022, its largest moves.
- Year by year, Income from Continuing Operations stood at 5318000.0 in 2021, then sank by 46.8% to 2829000.0 in 2022, then jumped by 48.82% to 4210000.0 in 2023, then sank by 63.28% to 1546000.0 in 2024, then plunged by 304.85% to 3167000.0 in 2025.
- Per Business Quant, the three latest SRTS Income from Continuing Operations figures stand at 3167000.0 (Q4 2025), 943000.0 (Q3 2025), and 1037000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.17 Mn |
| Sep 30, 2025 | -943,000.00 |
| Jun 30, 2025 | -1.04 Mn |
| Mar 31, 2025 | -2.57 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | -1.45 Mn |
| Jun 30, 2023 | -380,000.00 |
| Mar 31, 2023 | -1.89 Mn |
| Dec 31, 2022 | 2.83 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | -631.29 Mn |
| Dec 31, 2021 | 5.32 Mn |
| Sep 30, 2021 | 195,000.00 |
| Jun 30, 2021 | -279,000.00 |
| Mar 31, 2021 | -1.12 Mn |